サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：アレルギー治療薬の世界市場：産業分析、規模、シェア、成長、動向、予測（2023～2030年）
市場調査レポート
商品コード
1377827

アレルギー治療薬の世界市場：産業分析、規模、シェア、成長、動向、予測（2023～2030年）

Global Allergy Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日: | 発行: Value Market Research | ページ情報: 英文 190 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
アレルギー治療薬の世界市場：産業分析、規模、シェア、成長、動向、予測（2023～2030年）
出版日: 2023年09月01日
発行: Value Market Research
ページ情報: 英文 190 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のアレルギー治療薬の市場規模は、2022年に229億米ドルに達し、2023～2030年にかけてCAGR 7.4%で成長し、2030年には405億4,000万米ドルに達すると予測されています。

アレルギー治療薬は、アレルギー免疫療法またはアレルギー注射としても知られ、アレルギーを持つ個人が特定のアレルゲン（アレルギー反応を引き起こす物質）に対する耐性を構築するのを助けるように設計された医学的治療法です。アレルギーとは、花粉、ダニ、ペットのフケ、特定の食物など、通常は無害な物質に対する免疫系の反応です。その結果、くしゃみ、かゆみ、鼻づまり、じんましん、場合によっては重篤なアレルギー反応を引き起こすこともあります。

市場力学

アレルギー性鼻炎、喘息、食物アレルギーなどの症状を含むアレルギーの世界の有病率の増加は、市場の成長にプラスの影響を与えています。ライフスタイルの変化、都市化、環境アレルゲンへの暴露がこの動向に寄与しており、個人は効果的なアレルギー管理ソリューションを求めるようになっています。舌下免疫療法（SLIT）錠剤のような革新的な選択肢を含む治療法の進歩は、患者に従来のアレルギー注射に代わる、より便利で個別化された選択肢を提供しています。さらに、アレルギーに対する患者の意識の高まりと教育が、ヘルスケア・インフラの改善と専門医療へのアクセス向上と相まって、アレルギー治療薬に対する需要の高まりにつながっています。アレルギー検査の技術的進歩、効果的なアレルギー管理を促進する政府の取り組み、職業性アレルギーの認知が、市場をさらに強化しています。食物アレルギーの増加、世界の旅行、昆虫毒アレルギー治療の必要性も市場成長に寄与しています。現在進行中の研究、臨床試験、製薬会社と学術機関の共同研究が、新しく改良されたアレルギー治療薬の開発を促進しています。アレルギーが公衆衛生と福祉に影響を与え続ける中、アレルギー管理のより効果的で個別化された選択肢を個人に提供することで、市場の拡大が見込まれています。

この調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析を対象としています。これらのツールは、業界の構造を明確に把握し、競合の魅力を世界レベルで評価するのに役立ちます。さらに、これらのツールは、アレルギー治療薬の世界市場における各セグメントを包括的に評価することもできます。アレルギー治療薬業界の成長と動向は、この調査に全体的なアプローチを提供します。

地域分析

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおけるアレルギー治療薬市場の現在および将来の需要を強調する地域展望をカバーしています。さらに、著名な全地域にわたる個々の用途セグメントの需要・推定・予測にも焦点を当てています。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場ハイライト
  • 世界市場スナップショット

第3章 アレルギー治療薬 - 産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 アレルギー治療薬の世界市場分析：治療タイプ別

  • 概要：治療タイプ別
  • 実績データと予測データ
  • 分析：治療タイプ別
  • 抗アレルギー薬（抗ヒスタミン薬、副腎皮質ステロイド薬、その他の薬剤）
  • 免疫療法（皮下免疫療法（SCIT）、舌下免疫療法（SLIT）

第6章 アレルギー治療薬の世界市場分析：タイプ別

  • 概要：タイプ別
  • 実績データと予測データ
  • 分析：タイプ別
  • 眼アレルギー
  • 喘息
  • 皮膚アレルギー
  • 食物アレルギー
  • 鼻炎
  • その他のアレルギー

第7章 アレルギー治療薬の世界市場分析：投与経路別

  • 概要：投与経路別
  • 実績データと予測データ
  • 分析：投与経路別
  • 経口
  • 吸入薬
  • 経鼻剤
  • その他の投与経路

第8章 アレルギー治療薬の世界市場分析：流通チャネル別

  • 概要：流通チャネル別
  • 実績データと予測データ
  • 分析：流通チャネル別
  • 病院薬局
  • 小売薬局
  • その他の流通チャネル

第9章 アレルギー治療薬の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第10章 アレルギー治療薬企業の競合情勢

  • アレルギー治療薬市場の競合
  • 提携・協力・合意
  • 合併・買収
  • 新製品の上市
  • その他の開発

第11章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Allergopharma
  • Danaher
  • AbbVie Inc.
  • Allergy Therapeutics plc
  • Sanofi SA
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • GlaxoSmithKline plc
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co. Inc.
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Treatment Type (USD MN)
  • Anti-Allergy Drugs (Antihistamines, Corticosteroids., Other Drugs) Market Sales by Geography (USD MN)
  • Immunotherapy (Sub-Cutaneous Immunotherapy (SCIT), Sub-Lingual Immunotherapy (SLIT)) Market Sales by Geography (USD MN)
  • Analysis Market by Type (USD MN)
  • Eye Allergy Market Sales by Geography (USD MN)
  • Asthma Market Sales by Geography (USD MN)
  • Skin Allergy Market Sales by Geography (USD MN)
  • Food Allergies Market Sales by Geography (USD MN)
  • Rhinitis Market Sales by Geography (USD MN)
  • Other Allergy Types Market Sales by Geography (USD MN)
  • Analysis by Route Of Administration (USD MN)
  • Oral Market Sales by Geography (USD MN)
  • Inhalers Market Sales by Geography (USD MN)
  • Intranasal Market Sales by Geography (USD MN)
  • Other Routes Of Administration Market Sales by Geography (USD MN)
  • Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales by Geography (USD MN)
  • Retail Pharmacies Market Sales by Geography (USD MN)
  • Other Distribution Channels Market Sales by Geography (USD MN)
  • Global Allergy Therapeutics Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Allergy Therapeutics Report
  • Market Research Process
  • Market Research Methodology
  • Global Allergy Therapeutics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Treatment Type
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Route Of Administration
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Treatment Type (USD MN)
  • Anti-Allergy Drugs (Antihistamines, Corticosteroids., Other Drugs) Market Sales by Geography (USD MN)
  • Immunotherapy (Sub-Cutaneous Immunotherapy (SCIT), Sub-Lingual Immunotherapy (SLIT)) Market Sales by Geography (USD MN)
  • Global Market Analysis by Type (USD MN)
  • Eye Allergy Market Sales by Geography (USD MN)
  • Asthma Market Sales by Geography (USD MN)
  • Skin Allergy Market Sales by Geography (USD MN)
  • Food Allergies Market Sales by Geography (USD MN)
  • Rhinitis Market Sales by Geography (USD MN)
  • Other Allergy Types Market Sales by Geography (USD MN)
  • Global Market Analysis by Route Of Administration (USD MN)
  • Oral Market Sales by Geography (USD MN)
  • Inhalers Market Sales by Geography (USD MN)
  • Intranasal Market Sales by Geography (USD MN)
  • Other Routes Of Administration Market Sales by Geography (USD MN)
  • Global Market Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales by Geography (USD MN)
  • Retail Pharmacies Market Sales by Geography (USD MN)
  • Other Distribution Channels Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112112190

The global demand for Allergy Therapeutics Market is presumed to reach the market size of nearly USD 40.54 BN by 2030 from USD 22.9 BN in 2022 with a CAGR of 7.4% under the study period 2023 - 2030.

Allergy therapeutics, also known as allergy immunotherapy or allergy shots, are medical treatments designed to help individuals with allergies build a tolerance to specific allergens (substances that trigger allergic reactions). Allergy is an immune system response to normally harmless substances like pollen, dust mites, pet dander, or certain foods. This can lead to sneezing, itching, congestion, hives, or even severe allergic reactions in some cases.

MARKET DYNAMICS:

The increasing prevalence of allergies worldwide, including conditions like allergic rhinitis, asthma, and food allergies, is positively affecting the market growth. Lifestyle changes, urbanization, and exposure to environmental allergens contribute to this trend, prompting individuals to seek effective allergy management solutions. Advancements in treatment modalities, including innovative options like sublingual immunotherapy (SLIT) tablets, offer patients more convenient and personalized alternatives to traditional allergy shots. Additionally, heightened patient awareness and education about allergies, coupled with improved healthcare infrastructure and access to specialized care, have led to greater demand for allergy therapeutics. Technological advancements in allergy testing, government initiatives promoting effective allergy management, and the recognition of occupational allergies further bolster the market. The rise in food allergies, global travel, and the need for insect venom allergy treatments also contribute to market growth. Ongoing research, clinical trials, and collaborations between pharmaceutical companies and academic institutions are driving the development of new and improved allergy therapeutics. As allergies continue to impact public health and well-being, the market is expected to expand, providing individuals with more effective and personalized options for allergy management.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of allergy therapeutics. The growth and trends of allergy therapeutics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the allergy therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Treatment Type

  • Anti-Allergy Drugs (Antihistamines, Corticosteroids., Other Drugs)
  • Immunotherapy (Sub-Cutaneous Immunotherapy (SCIT), Sub-Lingual Immunotherapy (SLIT))

By Type

  • Eye Allergy
  • Asthma
  • Skin Allergy
  • Food Allergies
  • Rhinitis
  • Other Allergy Types

By Route Of Administration

  • Oral
  • Inhalers
  • Intranasal
  • Other Routes Of Administration

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Other Distribution Channels

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Allergy Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Allergy Therapeutics market include Allergopharma, Danaher, AbbVie Inc., Allergy Therapeutics plc, Sanofi SA, Pfizer Inc., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., and Merck & Co., Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . ALLERGY THERAPEUTICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Treatment Type
    • 3.7.2 Market Attractiveness Analysis By Type
    • 3.7.3 Market Attractiveness Analysis By Route Of Administration
    • 3.7.4 Market Attractiveness Analysis By Distribution Channel
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL ALLERGY THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE

  • 5.1 Overview by Treatment Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Treatment Type
  • 5.4 Anti-Allergy Drugs (Antihistamines, Corticosteroids., Other Drugs) Historic and Forecast Sales by Regions
  • 5.5 Immunotherapy (Sub-Cutaneous Immunotherapy (SCIT), Sub-Lingual Immunotherapy (SLIT)) Historic and Forecast Sales by Regions

6 . GLOBAL ALLERGY THERAPEUTICS MARKET ANALYSIS BY TYPE

  • 6.1 Overview by Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Type
  • 6.4 Eye Allergy Historic and Forecast Sales by Regions
  • 6.5 Asthma Historic and Forecast Sales by Regions
  • 6.6 Skin Allergy Historic and Forecast Sales by Regions
  • 6.7 Food Allergies Historic and Forecast Sales by Regions
  • 6.8 Rhinitis Historic and Forecast Sales by Regions
  • 6.9 Other Allergy Types Historic and Forecast Sales by Regions

7 . GLOBAL ALLERGY THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 7.1 Overview by Route Of Administration
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Route Of Administration
  • 7.4 Oral Historic and Forecast Sales by Regions
  • 7.5 Inhalers Historic and Forecast Sales by Regions
  • 7.6 Intranasal Historic and Forecast Sales by Regions
  • 7.7 Other Routes Of Administration Historic and Forecast Sales by Regions

8 . GLOBAL ALLERGY THERAPEUTICS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 8.1 Overview by Distribution Channel
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Distribution Channel
  • 8.4 Hospital Pharmacies Historic and Forecast Sales by Regions
  • 8.5 Retail Pharmacies Historic and Forecast Sales by Regions
  • 8.6 Other Distribution Channels Historic and Forecast Sales by Regions

9 . GLOBAL ALLERGY THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. South East Asia Sales Analysis
    • 9.5.10. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE ALLERGY THERAPEUTICS COMPANIES

  • 10.1. Allergy Therapeutics Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF ALLERGY THERAPEUTICS INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Allergopharma
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Danaher
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. AbbVie Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Allergy Therapeutics plc
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Sanofi SA
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Pfizer Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Teva Pharmaceutical Industries Ltd.
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. GlaxoSmithKline plc
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. F. Hoffmann-La Roche Ltd.
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Merck & Co. Inc.
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies